Summary & Overview
HCPCS Level II Q4287: Dermabind topical wound closure, per cm2
HCPCS Level II code Q4287 designates Dermabind dl, billed per square centimeter as an add-on product reported in addition to a primary procedure. The code captures use of a topical adjunctive wound closure material where surface area measurement is used for billing. Nationally, an add-on HCPCS code like Q4287 matters because it affects how procedural supply costs are documented and reimbursed alongside primary closure or surgical services.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for topical wound closure products, typical sites of service where the product is used, and how add-on HCPCS codes are applied in billing workflows. The publication summarizes expected billing considerations, common modifiers associated with procedural add-ons, and comparator codes when available.
The analysis provides benchmarks and coding guidance relevant to revenue cycle and clinical staff, highlights potential policy implications for coverage and claims adjudication, and outlines areas where coding clarity can affect reimbursement and compliance. Data not available in the input is clearly noted where applicable.
Billing Code Overview
HCPCS Level II code Q4287 denotes Dermabind dl, billed per square centimeter and is designated as an add-on, list separately in addition to primary procedure. This code represents the use of a Dermabind topical wound closure product measured and reported by surface area.
-
Service type: Topical wound closure application (adjunctive product)
-
Typical site of service: Ambulatory surgical centers, hospital outpatient departments, physician offices, and other procedural settings where primary wound closure or related procedures are performed
Clinical & Coding Specifications
Clinical Context
Dermabind Q4287 is an add-on topical adhesive product billed per square centimeter used to augment wound closure after dermatologic or minor surgical procedures. A typical patient scenario involves an adult patient undergoing excision of a cutaneous lesion (e.g., benign nevus, basal cell carcinoma) in an outpatient dermatology clinic or ambulatory surgical center. After hemostasis is achieved and layered closure performed (sutures or primary closure), the provider applies Dermabind over the incision to reinforce the closure, reduce tension, and protect the wound from moisture and contamination. The clinical workflow includes pre-procedure consent and diagnosis coding, the primary procedure (e.g., lesion excision or repair), measurement of the area requiring adhesive application in square centimeters, documentation of product name Dermabind, quantity (cm2), and indication, application of the product by the surgeon or delegated clinical staff, and postoperative wound care instructions. Typical sites of service are outpatient clinic, physician office, ambulatory surgical center, and hospital outpatient department. Common patient indications include surgical skin excisions, traumatic laceration repairs where additional topical adhesive support is clinically indicated, and situations where decreased tension or waterproofing is desired over a repaired incision.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |